Korean J Radiol.  2024 Sep;25(9):843-850. 10.3348/kjr.2024.0334.

Radiation Recall Pneumonitis: Imaging Appearance and Differential Considerations

• Jo NC
• Shroff GS
• Ahuja J
• Agrawal R
• Price MC
• Wu CC

• KMID: 2558919
• DOI: http://doi.org/10.3348/kjr.2024.0334

Abstract

Radiation recall pneumonitis is an inflammatory reaction of previously radiated lung parenchyma triggered by systemic pharmacological agents (such as chemotherapy and immunotherapy) or vaccination. Patients present with non-specific symptoms such as cough, shortness of breath, or hypoxia soon after the initiation of medication or vaccination. Careful assessment of the patient’s history, including the thoracic radiation treatment plan and timing of the initiation of the triggering agent, in conjunction with CT findings, contribute to the diagnosis. Once a diagnosis is established, treatment includes cessation of the causative medication and/or initiation of steroid therapy. Differentiating this relatively rare entity from other common posttherapeutic complications in oncology patients, such as recurrent malignancy, infection, or medication-induced pneumonitis, is essential for guiding downstream clinical management.

Keyword

Radiation-induced pneumonitis; Radiation-induced pneumonitis; Radiation therapy; Radiation therapy; Immunotherapy; Immunotherapy; COVID-19-related complications; COVID-19-related complications; Chemotherapy complication; Chemotherapy complication